(MENAFN- GlobeNewsWire - Nasdaq) The main market opportunities include training on modern technologies for computer system validation, compliance with evolving FDA regulations, and risk-based ...

As new consumer hardware and software capabilities have bumped up against medicine over the last few years, consumers and manufacturers alike have struggled with identifying the line between “wellness ...

Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

XINGTAI CITY, HEBEI PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- Sealing technology has become increasingly ...

Many organizations are operating with constrained resources while trying to expand, launch new therapies, or scale ...

SimBioSys®, an AI-driven precision medicine company revolutionizing how cancer is understood and treated, today announced the appointment of Senthil Periaswamy, PhD, as Chief AI & Technology Officer.

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals ...

Both the UK and US Governments have pledged to end research using animals, but is such a goal realistic? And how might it change medical research? Talha Burki reports.

The latest round of strategic seed funding is propelling innovations in imaging, brain health, autoimmune therapies, and more ...

Northwestern University recently awarded more than $2 million to eight innovative projects through the Pat & Shirley Ryan Family Research Acceleration ...